Recursion Pharmaceuticals | 4:持股变动声明-董事 Borgeson Blake
Recursion Pharmaceuticals | 4:持股变动声明-高管 Gibson Christopher
Recursion Pharmaceuticals | 4/A:持股变动声明(修正)-高管 Gibson Christopher
Recursion Pharmaceuticals | 4:持股变动声明-高管 Secora Michael
Recursion Pharmaceuticals | 4:持股变动声明-董事 Borgeson Blake
Recursion Pharmaceuticals | SC 13G:超过5%持股股东披露文件-RA Capital Management, L.P.(5.9%),Peter Kolchinsky(5.9%)等
Recursion Pharmaceuticals | 4:持股变动声明-董事 Borgeson Blake
Recursion Pharmaceuticals | 4:持股变动声明-董事 Burrell Terry-Ann
Recursion Pharmaceuticals | 4:持股变动声明-董事 Dar Zavain
Recursion Pharmaceuticals | 4:持股变动声明-董事 Li Dean Y
Recursion Pharmaceuticals | 4:持股变动声明-高管 Marriott Tina
Recursion Pharmaceuticals | 4:持股变动声明-董事 Borgeson Blake
Recursion Pharmaceuticals | 4:持股变动声明-高管 Secora Michael
Recursion Pharmaceuticals | 4:持股变动声明-董事 Borgeson Blake
Recursion Pharmaceuticals | 4:持股变动声明-高管 Gibson Christopher
Recursion Pharmaceuticals | 4:持股变动声明-董事 Burrell Terry-Ann
Recursion Pharmaceuticals | 4:持股变动声明-董事 HERSHBERG ROBERT
Recursion Pharmaceuticals | 4:持股变动声明-董事 Borgeson Blake
Recursion Pharmaceuticals | 4:持股变动声明-董事 Dar Zavain
Recursion Pharmaceuticals | 4:持股变动声明-董事 Li Dean Y
暂无数据